Vanguard Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
|
|||||
|
2025
Q1 | $14.1M | Buy |
|
|||||
|
2024
Q4 | $15.6M | Sell |
|
|||||
|
2024
Q3 | $16.3M | Buy |
|
|||||
|
2024
Q2 | $15.6M | Buy |
|
|||||
|
2024
Q1 | $19.1M | Buy |
|
|||||
|
2023
Q4 | $14M | Buy |
|
|||||
|
2023
Q3 | $13.7M | Buy |
|
|||||
|
2023
Q2 | $16.9M | Sell |
|
|||||
|
2023
Q1 | $15.4M | Sell |
|
|||||
|
2022
Q4 | $29.3M | Sell |
|
|||||
|
2022
Q3 | $43.2M | Buy |
|
|||||
|
2022
Q2 | $51M | Buy |
|
|||||
|
2022
Q1 | $48.6M | Buy |
|
|||||
|
2021
Q4 | $51.7M | Buy |
|
|||||
|
2021
Q3 | $182M | Buy |
|
|||||
|
2021
Q2 | $97.4M | Buy |
|
|||||
|
2021
Q1 | $68.4M | Buy |
|
|||||
|
2020
Q4 | $45.3M | Buy |
|